Radioiodine (131I) treatment decision-making for low- and intermediate-risk differentiated thyroid cancer.

Gao, Haiyan; Huang, Jiyuan; Dai, Qingjing; Su, Juan

Gao, Haiyan; Huang, Jiyuan; Dai, Qingjing; Su, Juan.

Afiliação

Gao H; Department of Nuclear Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Sichuan Province, China.
Huang J; Department of Nuclear Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Sichuan Province, China, huangjiyuan88@163.com.
Dai Q; Department of Nuclear Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Sichuan Province, China.
Su J; Department of Nuclear Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Sichuan Province, China.

Arch Endocrinol Metab ; 67(2): 197-205, 2023 Mar 10.

Article em En | MEDLINE | ID: mdl-36651706

Assuntos

Adenocarcinoma; Neoplasias da Glândula Tireoide; Masculino; Feminino; Humanos; Neoplasias da Glândula Tireoide/patologia; Radioisótopos do Iodo/uso terapêutico; Tireoglobulina; Estudos Retrospectivos; Tireoidectomia; Fatores de Risco

Palavras-chave

Differentiated thyroid cancer; low and intermediate-risk; radioactive iodine [<sup>131</sup>I] treatment

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Glândula Tireoide / Adenocarcinoma Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Arch Endocrinol Metab Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Brasil

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google